MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...

STAMFORD, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE:PBI) (“Pitney Bowes” or, the “Company”) today announced that it intends to offer, subject to market and other conditions, $200 million ...

$1.15 billion 0.00% Convertible Senior Notes offering (27.50% conversion premium) The repurchase of approximately $460 million of the common stock from investors in the Convertible Notes CleanSpark ...